Voss Capital, LLC Cullinan Oncology, Inc. Transaction History
Voss Capital, LLC
- $1.07 Billion
- Q1 2025
A detailed history of Voss Capital, LLC transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Voss Capital, LLC holds 175,000 shares of CGEM stock, worth $1.37 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
175,000
Previous 122,361
43.02%
Holding current value
$1.37 Million
Previous $1.49 Million
11.14%
% of portfolio
0.12%
Previous 0.13%
Shares
2 transactions
Others Institutions Holding CGEM
# of Institutions
155Shares Held
68.6MCall Options Held
15.6KPut Options Held
17.9K-
Bio Impact Capital LLC Cambridge, MA7.65MShares$59.7 Million10.72% of portfolio
-
Bvf Inc San Francisco, CA5.75MShares$44.9 Million1.91% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.86MShares$30.2 Million0.74% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$27.7 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY3.41MShares$26.7 Million15.23% of portfolio
About Cullinan Oncology, Inc.
- Ticker CGEM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,612,200
- Market Cap $356M
- Description
- Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...